PACS Group (NYSE:PACS) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. began coverage on shares of PACS Group (NYSE:PACS) in a report issued on Monday morning, MarketBeat reports. The firm issued an overweight rating and a $27.00 price objective on the stock.

Several other brokerages have also recently weighed in on PACS. Truist Financial assumed coverage on PACS Group in a research note on Monday. They set a buy rating and a $32.00 price objective on the stock. Royal Bank of Canada began coverage on shares of PACS Group in a research report on Monday. They set an outperform rating and a $30.00 price target on the stock. Citigroup began coverage on shares of PACS Group in a research report on Monday. They issued a buy rating and a $32.00 price objective for the company. Finally, Oppenheimer started coverage on shares of PACS Group in a research report on Monday. They set an outperform rating and a $31.00 target price on the stock. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of Buy and a consensus price target of $30.50.

PACS Group Stock Performance

Shares of PACS Group stock opened at $24.85 on Monday. PACS Group has a 52 week low of $22.61 and a 52 week high of $25.72.

Insider Buying and Selling at PACS Group

In other news, CEO Jason Hulse Murray sold 1,607,142 shares of the company’s stock in a transaction on Monday, April 15th. The stock was sold at an average price of $21.00, for a total transaction of $33,749,982.00. Following the transaction, the chief executive officer now owns 62,754,551 shares of the company’s stock, valued at approximately $1,317,845,571. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

About PACS Group

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.